A study conducted on the Intradermal, ID vaccine administration using the Tropis ID Needle-free Injection System, NFIS in ...

The primary objective was to enhance antitumor immunity through an innovative intradermal vaccination approach. Image Credit: Pand P Studio/Shutterstock.com This study aims to address the limitations ...

A study conducted on the Intradermal, ID vaccine administration using the Tropis ID Needle-free Injection System, NFIS in Nigeria has shown that switching to needle-free delivered fIPV could save the ...

Because the skin contains large numbers of antigen-presenting cells, intradermal vaccination often elicits antibody response more efficiently than does intramuscular vaccination. In two open-label ...

In August 2024, the World Health Organization (WHO) released an in-depth position paper addressing the use of vaccines ...

Vaccine for Central Nervous System Cancer is under clinical development by Immunomic Therapeutics and currently in Phase I for Anaplastic Astrocytoma.

such as the use of adjuvanted vaccines, boosting doses and intradermal vaccination, needs to be validated in appropriately powered clinical trials. The primary purpose of this article is to assess ...

Three varied producers – an outdoor breeding unit, a tented nursery and an indoor finisher – all displaying sound business ...

(“Ultimovacs”) (OSE ULTI), a clinical-stage biotechnology company developing novel immunotherapies against cancer, announces the presentation of updated data analysis from the UV1 Phase II NIPU trial ...

NPHCDA Executive Secretary, Muyi Aina, emphasised that migrating to needle-free fIPV could save Nigeria’s immunization programs $49.51m over five years.